The Effects of High Dose Sugammadex on Rat Kidney Tissue Following Unilateral Ureteral Obstruction
Abstract
Background: Unilateral ureteral obstruction (UUO) is commonly used model showed to imitate process of obstructive nephropathy in a feasible. The aim of this study is to evaluate the histopathological and biochemical effects of high doses sugammadex on kidney tissue of the rats those have early and late phase renal failure induced by UUO. Materials and Methods: Thirty male Wistar albino rats were randomly divided into five study groups. Control Group(C), UUO for 1 week Group(UUO-1), UUO-1 week treated with rocuronium and 96mg.kg-1 Sugammadex Group(UUO-1 week-96S), UUO for 3 weeks Group(UUO-3) and UUO-3 weeks treated with rocuronium and 96mg.kg-1 Sugammadex Group(UUO-3 week-96S). The blood samples are stored at -20 degrees and MDA and NO were studied in the serum. Kidney tissue was removed for histopathological examination. Results: In the histopathological examination of all parameters (glomerular vacuolization(GV), tubular dilatation(TD), Vascular vacuolisation and hypertrophy(VVH), tubular cell degeneration and necrosis(TCDN), Bowman's space dilatation(BSD), tubular hyaline cylinders(THC), lymphocyte infiltration(LI), tubular cell sloughing(TCS), significant difference was observed for the kidney at the obstruction side. After 3 weeks, in the side of the all unobstructed groups’ kidney tissues, significantly higher GV scores were detected compared with the GroupC. TD was observed more for the UUO1, UUO3 and UUO3S groups when compared with GroupC. And TCDN was observed more for the UUO1S and UUO3S groups when compared with GroupC. When the groups were compared with each other; it is observed that MDA and NO enzyme activities of UUO1S, UUO3 and UUO3S groups were significantly difference GroupC. Conclusion: High dose of sugammadex (96 mg.kg-1) can be used safely in UUO cases, on the other hand significant attention should be paid in bilateral ureteral obstruction cases. Our findings may be a guide for future animal and human studies investigating the effects of sugammadex on kidney tissue.References
Chevalier RL. Molecular and cellular pathophysiology of obstructive nephropathy. Pediatr Nephrol 1999; 13: 612-9.
Hu P, Zhao XQ, Wang J, Cai J, Hu B, Lu L, Xuan Q, Qin YH. Simplified stereological evaluation of renal morphology after unilateral ureteral obstruction. Int J Med Sci 2013;10:385-91.
Hu P, Wang J, Zhao XQ, Hu B, Lu L, Qin YH. Overexpressed C-type natriuretic peptide serves as an early compensatory response to counteract extracellular matrix remodeling in unilateral ureteral obstruction rats. Mol Biol Rep 2013;40: 1429-41.
Yang J, Dai C, Liu Y. Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial fibrosis in mice. J Am Soc Nephrol 2002;13: 2464-77.
Dicker SE, Shirley DG. Compensatory hypertrophy of the contralateral kidney after unilateral ureteral ligation. J Physiol 1972;220:199-210.
Hu P, Wang J, Hu B, Lu L, Xuan Q, Qin YH. Increased urinary C-type natriuretic peptide excretion may be an early marker of renal tubulointerstitial fibrosis. Peptides 2012; 37: 98-105.
Yıldız M, Pekdemir M, Akpolat N, Durukan P, Seçkin D, Çeliker H, Kavalcı C, Rahman A. Investigation of acute effects of diclofenac sodium on rat kidney with unilateral ureteral obstruction. Turk J Emerg Med. 2008; 8: 103-9.
Buder TF, Meistelman C, Raft J. Sugammadex: clinical development and practical use. Korean J Anesthesiol 2013;65: 495-500.
Baldo B. Sugammadex and rocuronium-induced anaphylaxis. Anaesthesia 2012;67: 1174-5.
Raft J, Betala Belinga JF, Jurkolow G, Desandes E, Longrois D, Meistelman C. Clinical evaluation of post-surgical bleeding after a sugammadex injection. Ann Fr Anesth Reanim 2011;30:714-7.
Bozkırlı F, Doğrul F, Comu FM, Arpacı H, Bayrak O, et al. The Effects of High-Dose Sugammadex on Erythrocyte Deformability in Rats with Renal Failure Generated by Unilateral Ureteral Obstruction. Int J Anesthetic Anesthesiol 2015; 2:032
Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990; 186: 407-21.
Cortas NK, Wakid NW. Determination of inorganic nitrate in serum ana urine by a kinetic cadmium-reduction method. Clin Chem 1990; 36: 1440-3.
Bostan H, Kalkan Y, Tomak Y, Tumkaya L, Altuner D, Yılmaz A, Erdivanlı B, Bedir R. Reversal of rocuronium-induced neuromuscular block with sugammadex and resulting histopathological effects in rat kidneys. Renal Fail 2011;33:1019-24.
Öztürk L, İzdeş S. Geriatrik Hastada Anestezik, Kas Gevşetici ve Kas Gevşeticilerin Etkisini Geri Döndüren İlaçların Güvenli Kullanımı. Türkiye Klinikleri J Anest Reanim-Special Topics 2011; 4:25-34.
Matteo RS, Ornstein E, Schwartz AE, Ostapkovich N, Stone JG. Pharmacokinetics and pharmacodynamics of rocuronium Org 9426 in elderly surgical patients. Anesth Analg 1993; 77:1193-7.
Büyükkoçak Ü. Sinir Kas Bloğunun Antagonize Edilmesi ve Sugammadeks. Türkiye Klinikleri J Anest Reanim-Special Topics 2011; 4:58-66.
Staals L, Snoeck M, Driessen J, et al. Mutlicentre, parallel-group, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function. Br J Anaesth 2008; 101:492–7.
Lobaz S, Sammut M, Damodaran A. Sugammadex rescue following prolonged rocuronium neuromuscular blockade with ‘recurarisation’ in a patient with severe renal failure. BMJ Case Rep 2013. pii: bcr2012007603. doi: 10.1136/bcr-2012-007603.
Staals L, Snoeck M, Driessen J, et al. Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study. Br J Anaesth 2010; 104:31–9.
Panhuizen IF, Gold SJ, Buerkle C, Snoeck MM, Harper NJ, Kaspers MJ, et al. Hollmann. Efficacy, safety and pharmacokinetics of sugammadex 4 mg /kg for reversal of deep neuromuscular blockade in patients with severe renal impairment. Br J Anaesth 2015; 114: 777–84.
Yokota N, Burne-Taney M, Racusen L, Rabb H. Contrasting roles for STAT4 and STAT6 signal transduction pathways in murine renal ischemia- reperfusion injury. Am J Physiol Renal Physiol 2003; 285: 319–25.
Devarajan P, Tarabishi R, Mishra J, et al. Low renal toxicity of lipoplatin compared to cisplatin in animals. Anticancer Res 2004; 24:2193–200.
Grande MT, López-Novoa JM. Fibroblast activation and myofibroblast generation in obstructive nephropathy. Nat Rev Nephrol 2009; 5:319-28.
Dursun KA, Akyol İ, Karademir K, Baykal KV, Erden D. The role of free oxygen radicals in üreteral obstructions and the effects of verapamil and alfa tocopherol for treatment. Türk Üroloji Dergisi 2000; 26: 437-43.
Szenohradszky J, Fisher DM, Segredo V, et al. Pharmacokinetics of rocuronium bromide (ORG 9426) in patients with normal renal function or patients undergoing cadaver renal transplantation. Anesthesiology 1992; 77: 899-904.
Özer Ç, Gönül B. The effect of ascorbic acid administration on the liver oxidant processes in diabetic rats. Gazi Medical Journal 2006; 17: 196-9.
Halliwell B, Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 1993; 57:715-24.
Amore A, Coppo R. Immunological basis of inflammation in dialysis. Nephrol Dial Transplant 2002; 17:16-24.
Weiss SL. Tissue destruction by neutrophils. N Eng J Med 1989; 320:365-76.
Uchida K. Role of reactive aldehyde in cardiovascular disease. Free Radical Biol Med 2000; 28: 1685-96.
Zhou TB, Qin YH, Lei FY, Huang WF, Drummen GP. Association of prohibitin-1 and 2 with oxidative stress in rats with renal interstitial fibrosis. Mol Biol Rep 2014; 41:3033–43.
Correa-Costa M, Semedo P, Monteiro AP, Silva RC, Pereira RL, Goncalves GM, et al. Induction of heme oxygenase-1 can halt and even reverse renal tubule-interstitial fibrosis. PLoS One 2010; 5: e14298.
Morisada N, Nomura M, Nishii H, Furuno Y, Sakanashi M, Sabanai K, et al. Complete disruption of all nitric oxide synthase genes causes markedly accelerated renal lesion formation following unilateral ureteral obstruction in mice in vivo. J Pharmacol Sci 2010; 114:379-89.
Taccone-Gallucci M, Giardini O, Lubrano R and et al. Red blood cell lipit peroxidation in predialysis chronic renal failure. Clin Nephrol 1987; 27: 238-41.
Lipinski B. Hydroxyl Radical and Its Scavengers in Health and Disease. Hindawi Publishing Corporation Oxidative Medicine and Cellular Longevity Volume 2011; 1-9.
Murrell GA, Doland MM, Jang D, Szabo C, Warren RF, Hannafin JA. Nitric oxide: An important articular free radical. J Bone Joint Surg Am 1996; 78:265-74.
Aiello S, Noris M, Remuzzi G. Nitric oxide/L- arginine in uremia. Miner Electrolyte Metab 1999; 25: 4-6.
Meenakshi SR, Agarwal R. Nitric oxide levels in patients with chronic renal disease. J Clin Diagn Res 2013; 7: 1288-90.
Kılıç I, Kılıç BA, Güven C, Demirpençe E, Akşit MA. Role of Nitric Oxide in Hypoxia-Induced Changes in Newborn Rats. Biol Neonate 2000; 78:191-97.
